Advertisement

Author: Staff

At the Morgan Stanley Global Healthcare Conference on Sept. 9 in New York City, Tenet CEO Ron Rittenmeyer discussed the company's performance and what to expect from both its hospital and ASC segments in the future.

Switzerland-based immuno-transcriptomics company Novigenix SA said its blood-based colorectal cancer test delivered encouraging results.

Advertisement

The more complex healthcare becomes, the more ambulatory surgery centers (ASCs) and surgical hospitals need to stay abreast of new trends—and understand how to turn them into new opportunities. To get started, here are some of the key drivers impacting the industry…

Advertisement